The greater tendency of insulin resistance in non-LPL FCS may suggest a contribution of this secondary factor to severe hypertriglyceridaemia or the effect of non-LPL gene products in governing insulin sensitivity. This evidence concerns the gene LPL and hypertriglyceridemia.